Literature DB >> 7841069

Pathology of craniopharyngiomas: clinical import of pathological findings.

D C Miller1.   

Abstract

Craniopharyngiomas are benign neoplasms, thought to be of maldevelopmental origin, which occur in both children and adults in the sella and suprasellar regions. There are two distinctive histologic patterns, 'adamantinomatous' and 'squamous papillary', but transitional or mixed examples occur. Prior suggestions that squamous papillary tumors are found 'only' in adults, 'never' calcify, do not invade brain, and are associated with a better outcome ('no' recurrences, better clinical status) are partially correct, but rare pediatric examples occur, rare examples have calcification, and in our study of 56 patients with craniopharyngiomas treated at New York University there was no statistically significant difference in brain invasion or recurrence rates for squamous papillary as compared to adamantinomatous types. Brain invasion, commonly seen in craniopharyngioma specimens, is not a predictor of recurrence.

Entities:  

Mesh:

Year:  1994        PMID: 7841069     DOI: 10.1159/000120855

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  20 in total

1.  Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas--a study in single institute.

Authors:  Sung Ho Moon; Il Han Kim; Seok Won Park; Inah Kim; Semie Hong; Charn Il Park; Kyu Chang Wang; Byung Kyu Cho
Journal:  Childs Nerv Syst       Date:  2005-06-14       Impact factor: 1.475

Review 2.  The pathogenesis of craniopharyngiomas.

Authors:  Vikram C Prabhu; Henry G Brown
Journal:  Childs Nerv Syst       Date:  2005-06-18       Impact factor: 1.475

3.  Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital.

Authors:  Tadanori Tomita; Robin M Bowman
Journal:  Childs Nerv Syst       Date:  2005-07-26       Impact factor: 1.475

4.  Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?

Authors:  Annett Hölsken; Christina Stache; Sven Martin Schlaffer; Jörg Flitsch; Rudolf Fahlbusch; Michael Buchfelder; Rolf Buslei
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

5.  Optimal treatment strategy for craniopharyngiomas based on long-term functional outcomes of recent and past treatment modalities.

Authors:  Takakazu Kawamata; Kosaku Amano; Yasuo Aihara; Osami Kubo; Tomokatsu Hori
Journal:  Neurosurg Rev       Date:  2010-01       Impact factor: 3.042

6.  Craniopharyngioma: a clinicopathological study of 141 cases.

Authors:  Seyed Mohammad Tavangar; Bagher Larijani; Ali Mahta; Seyed Mehdi Abdolahzadeh Hosseini; Masoud Mehrazine; Fatemeh Bandarian
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

7.  Monstrous craniopharyngioma. Case presentations and term proposal.

Authors:  Humberto Trejos; Adrian Caceres; Juan L Segura
Journal:  Childs Nerv Syst       Date:  2005-03-10       Impact factor: 1.475

8.  Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.

Authors:  SongTao Qi; GuangLong Huang; Jun Pan; Jia Li; Xi'An Zhang; LuXiong Fang; BaoGuo Liu; Wei Meng; YongMing Zhang; XiaoJun Liu
Journal:  J Neurooncol       Date:  2009-11-10       Impact factor: 4.130

9.  Management of recurrent pituitary cysts with pituitary-nasal drain.

Authors:  Umesh Dashora; David Mathias; Andy James; Ivan Zammit-Maempel; Petros Perros
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 10.  Craniopharyngioma: historical notes.

Authors:  J Lindholm; E H Nielsen
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.